To further evaluate the effect of ROCK2-knockdown on ferroptosis, we measured ROS, Fe2+, MDA, and reduced GSH/GSSG levels in shNC-Pemigatinib-resistant and shROCK2-Pemigatinib-resistant CCA cells. The gene discussed is ROCK2; the disease is cholangiocarcinoma.